Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Microbot Medical Inc. Director's Dealing 2010

Jul 2, 2010

33819_dirs_2010-07-01_b0b2b9d7-0f8e-4977-9eea-3ae35e531e97.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: STEMCELLS INC (STEM)
CIK: 0000883975
Period of Report: 2010-06-01

Reporting Person: Stratton Kenneth Blair (General Counsel)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2010-06-01 Common Stock A 200000 $0.00 Acquired 312274 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2010-06-01 Stock Option (right to purchase) $1.02 A 50000 Acquired 2020-06-01 Common Stock (50000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 1936 Indirect

Footnotes

F1: Includes (1) 200,000 restricted stock units, with 50,000 vesting on each of June 1, 2011, June 1, 2012, June 1, 2013, and June 1, 2014; (2) 70,000 restricted stock units, with 23,333 vesting on each of May 15, 2011, May 15, 2012 and May 15, 2013; and (3) 27,500 restricted stock units vesting on March 10, 2011.

F2: Shares held in 401(k) account in accordance with issuer's employer-match policies.

F3: Employee stock option; vests 1/4 on the first anniversary of the grant and 1/48 per month thereafter.